Hikma Pharma

Hikma Pharma is a Trust registered in Giza, Egypt and holds an LEI in its own name.

The LEI has been on record for 5 years, since 15 Jun 2021. That puts it right on the median for Egypt, where half of all LEIs date from before 2021.

Annual re-validation is 1604 days overdue: it fell due 15 Jun 2022. An LEI that is not re-validated lapses, which does not invalidate it but marks the reference data as unverified.

The record has not changed since we began archiving it on 6 Jul 2026. Any future change to name, status, address, ownership or renewal date will be captured here, because GLEIF publishes only the current state and superseded values are otherwise lost.

The entity is registered with Commercial Register under registry number 61804701001304, and the LEI itself is issued and maintained by EQS Group GmbH, one of the Local Operating Units accredited by GLEIF.

No direct accounting-consolidating parent is reported, because no controlling person is known. GLEIF requires this to be stated explicitly rather than left blank, so the absence is itself a data point.

No ultimate accounting-consolidating parent is reported, because no controlling person is known. GLEIF requires this to be stated explicitly rather than left blank, so the absence is itself a data point.

The LEI registration is lapsed, and the entity status (active) records whether the legal entity itself still exists. The two are independent: an LEI can lapse while the company trades on, and it can stay issued after the company has been dissolved.